Wolfgang A. Tomé

Wolfgang Axel Tomé is a Physicist working in Medicine as a researcher; inventor; and educator. He is noted for his contributions to the use of photogrammetry in high precision radiation therapy;[1] his work on risk adaptive radiotherapy which is based on the risk level for recurrence in a given tumor sub-volume using biological objective functions;[2] and the development of hippocampal avoidant cranial radiation therapy techniques to alleviate hippocampal-dependent neurocognitive impairment following cranial irradiation.[3]

Wolfgang Axel Tomé
Born
NationalityAmerican
Alma materUniversity of Florida
University of Denver
University of Tübingen
AwardsScholar of the Studienstiftung des Deutschen Volkes (1987)
Doctoral Scholar of the Studienstiftung des Deutschen Volkes (1992)
Fellow , American Association of Physicists in Medicine (FAAPM) (2010)
Fellow , American Society for Radiation Oncology (FASTRO) (2017)
Scientific career
FieldsPhysics, Mathematics, Medical Physics, Radiation Oncology, Neurology
InstitutionsAlbert Einstein College of Medicine
Montefiore Medical Center
University of Wisconsin
University of Wollongong
ThesisQuantization and Representation Independent Propagators (1995)
Doctoral advisorJohn R. Klauder
Other academic advisorsStanley P. Gudder

He is the author of Path Integrals on Group manifolds[4] and the co-author of Dose painting IMRT using Biological Parameters.[5] Together with Anatoly Pinchuk and Jamey Weichert, he is the inventor of long-lived tumor specific Gadolinium based agents for imaging and therapy.[6] He has more than 250 published articles in various areas of medical and mathematical physics (cf. PubMed,MATHSCINET) and 7 patents[7] to his credit. In addition, he has been actively in involved in a number of AAPM task groups[8] and the AAPM Working group on Biological Effects of Hypofractionated Radiotherapy/SBRT.

In recognition of his distinguished and significant contributions to the fields of medical physics and radiation oncology he has been bestowed the distinction and title of Fellow of the American Association of Physicists in Medicine (FAAPM) in 2010 and Fellow of the American Society for Radiation Oncology (FASTRO) in 2017.

References

  1. https://pubmed.ncbi.nlm.nih.gov/10863087/; https://pubmed.ncbi.nlm.nih.gov/11578726/
  2. https://pubmed.ncbi.nlm.nih.gov/10974480/; https://pubmed.ncbi.nlm.nih.gov/17126211/; https://pubmed.ncbi.nlm.nih.gov/20429729/
  3. https://pubmed.ncbi.nlm.nih.gov/17869672/; https://pubmed.ncbi.nlm.nih.gov/21697413/; https://pubmed.ncbi.nlm.nih.gov/20598457/; https://pubmed.ncbi.nlm.nih.gov/25605507/; https://pubmed.ncbi.nlm.nih.gov/23312272/; https://pubmed.ncbi.nlm.nih.gov/25349290/; https://pubmed.ncbi.nlm.nih.gov/32058845/
  4. Tomé W. Path Integrals on Group Manifolds: The Representation Independent Propagator for General Lie Groups. World Scientific Publishing Company, New York, 1998
  5. Kim Y and Tomé W. Dose painting IMRT using Biological Parameters. Scholars' Press, Saarbrücken, Germany, 2014
  6. Patent No. US 10,265,398 B2
  7. Patent No. US 6,974,254 B2; Patent No. US 7,508,967 B2; Patent No. US 7,551,717 B2; Patent No. US 8,526,692 B2; Patent No. US 8,897,857 B2; Patent No. US 10,007,961 B2; Patent No. US 10,265,398 B2
  8. AAPM TG 101: Stereotactic Body Radiation Therapy (SBRT); AAPM TG 147: QA for non-radiographic localization and positioning systems; AAPM TG 154: Quality Assurance of Ultrasound Guided Radiotherapy; and AAPM TG 302: Surface Image Guided Radiotherapy
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.